Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 17/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 13/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 6/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 8/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14918401 | 0.91 | HDAC6 (0.56) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918675 | 0.90 | HDAC6 (0.60) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918381 | 0.90 | HDAC6 (0.55) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918802 | 0.87 | HDAC6 (0.55) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918080 | 0.85 | HDAC6 (0.52) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918791 | 0.84 | HDAC6 (0.51) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918469 | 0.84 | HDAC6 (0.49) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918126 | 0.84 | HDAC6 (0.49) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918501 | 0.83 | HDAC6 (0.48) | HDAC6HDAC1HDAC5HDAC4HDAC8 | |
| SCHEMBL14918301 | 0.83 | HDAC6 (0.47) | HDAC6HDAC1HDAC5HDAC4HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013066835-A2 | COMPOUNDS AND METHODS | GLAXOSMITHKLINE LLC (US) | 2013-05-10 | — | — | WO | disclosed |